Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Theratechnologies Inc.
THTXCurrent price
1.22 USD
-0.035 USD (-2.79%)
Last closed
1.74 CAD
Company
www.theratech.com
ISIN
CA88338H1001
Sector
Healthcare
Industry
Biotechnology
Exchange
TO
Capitalization
82 388 243 CAD
Yield for 12 month
-5.46 %
1Y
3Y
5Y
10Y
15Y
THTX
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its pipeline products include F8 Formulation that is in Phase 2b/3 clinical trials for studying tesamorelin for the treatment of nonalcoholic steatohepatitis; multi -dose pen injector for the administration of tesamorelin; SORT1+ Technology Platform for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; Sudocetaxel Zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company was incorporated in 1993 and is headquartered in Montreal, Canada. Address: 2015 Peel Street, Montreal, QC, Canada, H3A 1T8
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
10.61 CADP/E ratio
–Dividend Yield
–Current Year
+114 588 975 CAD
Last Year
+112 196 683 CAD
Current Quarter
+31 672 996 CAD
Last Quarter
+30 855 945 CAD
Current Year
+87 071 308 CAD
Last Year
+75 367 716 CAD
Current Quarter
+25 336 995 CAD
Last Quarter
+24 483 506 CAD
Key Figures THTX
1 year
3 years
5 years
10 years
EBITDA
14 493 672 CAD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
11.76 %
PEG Ratio
-199
Return On Equity TTM
-1116.86 %
Wall Street Target Price
10.61 CAD
Revenue TTM
84 876 266 CAD
Book Value
-0.43 CAD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
8.4 %
Dividend Yield
–
Gross Profit TTM
56 592 566 CAD
Earnings per share
-0.06 CAD
Diluted Eps TTM
-0.06 CAD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-3.75 %
Dividend Analytics THTX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History THTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:4
Payout Ratio
–
Last Split Date
31.07.2023
Dividend Date
18.10.2000
Stock Valuation THTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
18.315
Enterprise Value Revenue
0.925
Price Sales TTM
0.9707
Enterprise Value EBITDA
6.7443
Price Book MRQ
19.4616
Financials THTX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators THTX
For 52 weeks
1.6 CAD
3.45 CAD
50 Day MA
1.73 CAD
Shares Short Prior Month
14 372
200 Day MA
1.87 CAD
Short Ratio
0.19
Shares Short
3 812
Short Percent
0.01 %
BeatStart